GlassScriptPhysician profile
Marc J Levine
NPI 1558339572
$502,100.80
in general payments reported to CMS, 2019-2025
37 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $90K · 2021: $117K · 2022: $102K · 2023: $74K · 2024: $39K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $71K · Royalty Or License: $42K · Travel and Lodging: $12K · Food and Beverage: $3,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $70,864.50 |
| Royalty Or License | $41,666.65 |
| Travel and Lodging | $11,589.95 |
| Food and Beverage | $3,261.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $400,165.10 | 2019-2023 | |
| Precision Spine, INC. | $41,722.60 | 2023-2025 | |
| Expanding Innovations, INC. | $15,414.50 | 2023-2025 | X-Pac |
| Circinus Medical Technology LLC | $12,389.66 | 2025 | Bolt Navigation |
| Heron Therapeutics, INC. | $9,819.17 | 2019-2022 | |
| Alphatec Spine, INC | $6,265.66 | 2023-2025 | Other - Miscellaneous, Battalion Tlif - PC, Invictus Open |
| 4web, INC. | $3,900.00 | 2023 | Spine Truss System |
| Medacta USA, INC. | $3,804.43 | 2024 | |
| Biedermann Motech, INC. | $3,599.23 | 2019-2020 | |
| Globus Medical, INC. | $951.66 | 2019-2024 | Excelsiusgps Robotic Navigation System |
| Nuvasive, INC. | $800.81 | 2019-2023 | Alif |
| Pacira Pharmaceuticals Incorporated | $658.19 | 2022-2024 | Iovera, Exparel, Zilretta |
| Medtronic, INC. | $405.78 | 2021-2024 | Mazor X System, Intellis Adaptivestim, Infinity Occipitocervical Upper Thoracic System |
| Camber Spine Technologies LLC | $273.00 | 2019 | |
| Degen Medical, INC. | $267.36 | 2025 | Plif, Alif |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $250.50 | 2019-2020 | |
| Cerapedics INC. | $194.44 | 2021-2023 | I-Factor Peptide Enhanced Bone Graft |
| Captiva Spine INC | $166.22 | 2024 | Transfasten |
| Medical Device Business Services, INC. | $142.85 | 2022 | |
| Boston Scientific Corporation | $133.37 | 2019-2025 | General - Pain Management |
| Zimmer Biomet Holdings, INC. | $122.85 | 2021 | |
| Depuy Synthes Sales INC. | $106.84 | 2019-2023 | Viper |
| Life Spine, INC. | $78.08 | 2023 | Prolift Lateral, Trulift, Prolift |
| Intrinsic Therapeutics | $77.55 | 2021 | |
| Corelink, LLC | $62.59 | 2019 | |
| Smith+Nephew, INC. | $60.19 | 2021-2022 | |
| Stryker Corporation | $42.20 | 2021 | |
| 7d Surgical INC. | $39.52 | 2020 | |
| Ossdsign USA Incorporated | $31.48 | 2025 | Ossdsign Catalyst |
| Spinal Elements, INC. | $25.50 | 2024 | |
| Ossur Americas, INC. | $23.36 | 2024 | Miami J |
| Centinel Spine, LLC | $21.43 | 2021 | |
| Ethicon US, LLC | $20.60 | 2022 | |
| Baxter Healthcare | $19.99 | 2019 | |
| Medtronic USA, INC. | $17.49 | 2020 | |
| Avanos Medical | $14.24 | 2023 | Trivisc Sodium Hyaluronate |
| Horizon Therapeutics Plc | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$117,334.36 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.